We start English website service. Thank you for waiting this.
Indication: Prevention of Hepatitis B
Remarks: Phase IIb Planning(Application: non-responder, high risk group, 2 dose vaccine)
Indication: Treatment of Chronic Hepatitis
Remarks: Phase I/IIa On going 4 Cohorts: 20 or 40 μg/dose for 3 or 6 injections in each dose
Indication: Prevention of Herpes Zoster (Shingles)
Remarks: Phase I On going
Indication: Prevention of seasonal Flu (high risk group)
Remarks: Feasibility Study
Indication: Suppression of infectious disease
Indication: Therapeutic vaccine